<DOC>
	<DOC>NCT01181908</DOC>
	<brief_summary>The purpose of this study is understand the effects of GSK114814 and alcohol in healthy volunteers when taken together.</brief_summary>
	<brief_title>Alcohol Interaction Study</brief_title>
	<detailed_description>The primary objective of this study is to investigate the CNS effects of co-administration of GSK1144814 with alcohol. Healthy volunteers who meet the eligibility criteria will be randomized to receive GSK1144814 or placebo with alcohol.</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Healthy male and female Body weight 50 kg or higher and BMI within the range 19 29.9 kg/m2 Willing to use appropriate contraception methods Positive HIV, Hepatitis B surface antigen or Hepatitis C antibody result Any serious medical disorder or condition Any history of an endocrine disorder. Any clinically significant laboratory abnormality. History of psychiatric illness. Any history of suicidal attempts or behavior. Positive urine drug screen or positive blood alcohol Pregnant, nursing or potential to have a child Past history of alcohol dependence or abuse. History of increased sensitivity to the effects of alcohol or violent behaviour/aggression when intoxicated. smokers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>alcohol</keyword>
	<keyword>drug interaction</keyword>
	<keyword>pharmacodynamic</keyword>
</DOC>